Tirzepatide Injection

Tirzepatide Injection is a research-grade formulation containing a synthetic dual incretin receptor agonist designed for laboratory investigation of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways. This peptide is classified as a dual GIP/GLP-1 receptor agonist and is utilized in preclinical research examining incretin hormone interactions, metabolic regulation, and pancreatic function mechanisms. Tirzepatide is an engineered peptide based on the native GIP sequence with structural modifications to confer dual receptor activity and enhanced pharmacological stability. This product is formulated as a research-grade injectable solution for controlled delivery in experimental models and is intended solely for scientific research purposes and is not for human or veterinary use.